ISPOR Value in Health Article Discusses Generating Cost-Effectiveness Analyses Using US Healthcare Data Based on Age and Disease

ISPOR’s Value in Health has published an article cataloguing healthcare costs and noting that cost-effectiveness analyses may allow for future medical cost calculations. The authors break down healthcare costs by age, 270 disease classifications, sex, and include costs of death.

The authors remark, “Consistent application of cost-effectiveness theory and recommendations from the Second Panel on Cost-Effectiveness in Health and Medicine suggests that all healthcare costs, related and unrelated, during extensions of life owing to an intervention (ie, future medical costs) should be accounted for. In addition, the costs of death are important components of total resource use.” Read the article here.

(Source: Boshen Jiao and Anirban Basu, Value in Health, 4/23/21)